OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype
Heather Fairfield, Amel Dudakovic, Casper M. Khatib, et al.
Cancer Research (2020) Vol. 81, Iss. 3, pp. 634-647
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Lipid metabolism in cancer: New perspectives and emerging mechanisms
Lindsay A. Broadfield, Antonino Alejandro Pane, Ali Talebi, et al.
Developmental Cell (2021) Vol. 56, Iss. 10, pp. 1363-1393
Open Access | Times Cited: 404

Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance
Zhiming Wang, Jin He, Duc‐Hiep Bach, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 81

Update on Adipose Tissue and Cancer
Kristy A. Brown, Philipp E. Scherer
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 961-974
Open Access | Times Cited: 44

Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins
Cristina Panaroni, Keertik Fulzele, Tomoaki Mori, et al.
Blood (2021) Vol. 139, Iss. 6, pp. 876-888
Open Access | Times Cited: 75

Cancer-associated adipocytes as immunomodulators in cancer
Qi Wu, Bei Li, Juanjuan Li, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 69

Obesity and multiple myeloma: Emerging mechanisms and perspectives
Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos, Evangelos Terpos
Seminars in Cancer Biology (2023) Vol. 92, pp. 45-60
Closed Access | Times Cited: 25

Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
Mariah Farrell, Heather Fairfield, Michelle Karam, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 24

Obesity and myeloma: Clinical and mechanistic contributions to disease progression
Constance Marques-Mourlet, Reagan Di Iorio, Heather Fairfield, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
Patricia Maiso, Pedro Mogollón, Enrique M. Ocio, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2542-2542
Open Access | Times Cited: 29

Metabolic crosstalk between stromal and malignant cells in the bone marrow niche
Hernán A. Tirado, Nithya Balasundaram, Lotfi Laaouimir, et al.
Bone Reports (2023) Vol. 18, pp. 101669-101669
Open Access | Times Cited: 11

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma
Bilal Mohamad El-Masri, Benedeta Leka, Fatima Mustapha, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 20-26
Open Access | Times Cited: 4

Bone Marrow Adipocytes as Novel Regulators of Metabolic Homeostasis: Clinical Consequences of Bone Marrow Adiposity
Hanghang Liu, Linyi Liu, Clifford J. Rosen
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access

Prognostic impact of a senescence gene signature in multiple myeloma
Andrea Ceglédi, Otília Menyhárt, Hajnalka Andrikovics, et al.
GeroScience (2025)
Open Access

SITC strategic vision: prevention, premalignant immunity, host and environmental factors
Sasha E. Stanton, Kristin G. Anderson, Tullia C. Bruno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010419-e010419
Open Access

Multiple myeloma metabolism – a treasure trove of therapeutic targets?
Mónica Román-Trufero, Holger W. Auner, Claire M. Edwards
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Turning the spotlight on bone marrow adipocytes in haematological malignancy and non‐malignant conditions
Michael J. Austin, Foteini Kalampalika, William P. Cawthorn, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 4, pp. 605-619
Open Access | Times Cited: 10

Clinical features and treatment of bone marrow metastasis
Hongliang Yang, Feng He, Yuan Tian, et al.
Oncology Letters (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 9

Bone marrow adiposity modulation after long duration spaceflight in astronauts
Tammy Liu, Gerd Melkus, Tim Ramsay, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9

Correlation Between Bariatric Surgery and the Risk of Multiple Myeloma: Results from an Evidence-Based Strategy
Qiong Wu, Tiantian Zhao, Chenglou Zhu, et al.
Obesity Surgery (2024) Vol. 34, Iss. 4, pp. 1061-1072
Closed Access | Times Cited: 3

Adipocytes and metabolism: Contributions to multiple myeloma
Heather Fairfield, Michelle Karam, Allyson Schimelman, et al.
Journal of bone oncology (2024) Vol. 46, pp. 100609-100609
Open Access | Times Cited: 3

Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells
Kuntal Bhowmick, Max Von Suskil, Omar S. Al‐Odat, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33091-e33091
Open Access | Times Cited: 3

Immune mediated support of metastasis: Implication for bone invasion
Zengfeng Xin, Luying Qin, Yang Tang, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 967-991
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top